期刊论文详细信息
EJNMMI Research | |
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients | |
Hans-Jürgen Wester1  Peter Herhaus2  Maike Hefter2  Wolfgang Weber3  Valëza Ademaj-Kospiri3  Caroline Anna Peuker4  Richard Lewis4  Stefan Habringer5  Ulrich Keller6  Andreas Buck7  Rudolf Werner7  Malte Kircher8  Alexander Gäble8  Constantin Lapa8  | |
[1] Chair of Pharmaceutical Chemistry, Technical University of Munich, Garching, Germany;Clinic and Policlinic for Internal Medicine III, School of Medicine, Technical University of Munich, Munich, Germany;Clinic for Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany;Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany;Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany;Berlin Institute of Health (BIH), Berlin, Germany;Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany;German Cancer Consortium (DKTK), Partner Site Berlin; and German Cancer Research Center (DKFZ), Heidelberg, Germany;Max-Delbrück-Center for Molecular Medicine, Berlin, Germany;Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany;Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany; | |
关键词: Solid tumors; Clinical studies; Retrospective studies; Molecular imaging; PET; CXCR4; Pentixafor; Spleen; Uptake; | |
DOI : 10.1186/s13550-021-00822-6 | |
来源: Springer | |